|
1
|
Lönn S, Klaeboe L, Hall P, Mathiesen T,
Auvinen A, Christensen HC, Johansen C, Salminen T, Tynes T and
Feychting M: Incidence trends of adult primary intracerebral tumors
in four Nordic countries. Int J Cancer. 108:450–455. 2004.
View Article : Google Scholar
|
|
2
|
Houben MP, Aben KK, Teepen JL,
Schouten-Van Meeteren AY, Tijssen CC, Van Duijn CM and Coebergh JW:
Stable incidence of childhood and adult glioma in the Netherlands,
1989–2003. Acta Oncol. 45:272–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Merchant TE, Pollack IF and Loeffler JS:
Brain tumors across the age spectrum: Biology, therapy, and late
effects. Semin Radiat Oncol. 20:58–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Candolfi M, Curtin JF, Nichols WS,
Muhammad AG, King GD, Pluhar GE, McNiel EA, Ohlfest JR, Freese AB,
Moore PF, et al: Intracranial glioblastoma models in preclinical
neuro-oncology: Neuropathological characterization and tumor
progression. J Neurooncol. 85:133–148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huse JT and Holland EC: Genetically
engineered mouse models of brain cancer and the promise of
preclinical testing. Brain Pathol. 19:132–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laerum OD and Rajewsky MF: Neoplastic
transformation of fetal rat brain cells in culture after exposure
to ethylnitrosourea in vivo. J Natl Cancer Inst. 55:1177–1187.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laerum OD, Rajewsky MF, Schachner M,
Stavrou D, Haglid KG and Haugen A: Phenotypic properties of
neoplastic cell lines developed from fetal rat brain cells in
culture after exposure to ethylnitrosourea in vivo. Z Krebsforsch
Klin Onkol Cancer Res Clin Oncol. 89:273–295. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sampson JH, Ashley DM, Archer GE, Fuchs
HE, Dranoff G, Hale LP and Bigner DD: Characterization of a
spontaneous murine astrocytoma and abrogation of its tumorigenicity
by cytokine secretion. Neurosurgery. 41:1365–1373. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serano RD, Pegram CN and Bigner DD:
Tumorigenic cell culture lines from a spontaneous VM/Dk murine
astrocytoma (SMA). Acta Neuropathol. 51:53–64. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Vries NA, Bruggeman SW, Hulsman D, de
Vries HI, Zevenhoven J, Buckle T, Hamans BC, Leenders WP, Beijnen
JH, van Lohuizen M, et al: Rapid and robust transgenic high-grade
glioma mouse models for therapy intervention studies. Clin Cancer
Res. 16:3431–3441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marumoto T, Tashiro A, Friedmann-Morvinski
D, Scadeng M, Soda Y, Gage FH and Verma IM: Development of a novel
mouse glioma model using lentiviral vectors. Nat Med. 15:110–116.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanu OO, Hughes B, Di C, Lin N, Fu J,
Bigner DD, Yan H and Adamson C: Glioblastoma multiforme
oncogenomics and signaling pathways. Clin Med Oncol. 2009:39–52.
2009.
|
|
13
|
Barker FG, Chang SM, Larson DA, Sneed PK,
Wara WM, Wilson CB and Prados MD: Age and radiation response in
glioblastoma multiforme. Neurosurgery. 49:1288–1298. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ng WH, Wan GQ and Too HP: Higher
glioblastoma tumour burden reduces efficacy of chemotherapeutic
agents: In vitro evidence. J Clin Neurosci. 14:261–266. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stewart LA: Chemotherapy in adult
high-grade glioma: A systematic review and meta-analysis of
individual patient data from 12 randomised trials. Lancet.
359:1011–1018. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Katayama N, Sugimoto K, Okada T, Ueha T,
Sakai Y, Akiyoshi H, Mie K, Ueshima E, Sofue K, Koide Y, et al:
Intra-arterially infused carbon dioxide-saturated solution for
sensitizing the anticancer effect of cisplatin in a rabbit VX2
liver tumor model. Int J Oncol. 51:695–701. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Flecknell P: Laboratory animal
anaesthesia, Third edition. Acad Press; 2009
|
|
18
|
Clarke DL, Johansson CB, Wilbertz J,
Veress B, Nilsson E, Karlström H, Lendahl U and Frisén J:
Generalized potential of adult neural stem cells. Science.
288:1660–1663. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Castrén M, Tervonen T, Kärkkäinen V,
Heinonen S, Castrén E, Larsson K, Bakker CE, Oostra BA and Akerman
K: Altered differentiation of neural stem cells in fragile X
syndrome. Proc Natl Acad Sci USA. 102:17834–17839. 2005. View Article : Google Scholar
|
|
20
|
Ikawa M, Tanaka N, Kao WW and Verma IM:
Generation of transgenic mice using lentiviral vectors: A novel
preclinical assessment of lentiviral vectors for gene therapy. Mol
Ther. 8:666–673. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Follenzi A and Naldini L: HIV-based
vectors. Preparation and use. Methods Mol Med. 69:259–274.
2002.PubMed/NCBI
|
|
22
|
Leppänen P, Kholová I, Mähönen AJ, Airenne
K, Koota S, Mansukoski H, Närväinen J, Wirzenius M, Alhonen L,
Jänne J, et al: Short and long-term effects of hVEGF-A(165) in
Cre-activated transgenic mice. PLoS One. 1:e132006. View Article : Google Scholar
|
|
23
|
Close B, Banister K, Baumans V, Bernoth
EM, Bromage N, Bunyan J, Erhardt W, Flecknell P, Gregory N,
Hackbarth H, et al: Recommendations for euthanasia of experimental
animals: Part 1. DGXI of the European Commission. Lab Anim.
30:293–316. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of Tumors of the Central Nervous System: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang D, Henning TD, Zou LG, Hu LB, Wen L,
Feng XY, Dai SH, Wang WX, Sun QR and Zhang ZG: Intracranial
ganglioglioma: Clinicopathological and MRI findings in 16 patients.
Clin Radiol. 63:80–91. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karremann M, Pietsch T, Janssen G, Kramm
CM and Wolff JE: Anaplastic ganglioglioma in children. J
Neurooncol. 92:157–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rogojan L and Olinici CD: Ganglioglioma
with glioblastoma component. Rom J Morphol Embryol. 49:403–406.
2008.PubMed/NCBI
|
|
29
|
Rousseau A, Kujas M, Bergemer-Fouquet AM,
Effenterre R and Hauw JJ: Survivin expression in ganglioglioma. J
Neurooncol. 77:153–159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miller DC, Lang FF and Epstein FJ: Central
nervous system gangliogliomas. Part 1: Pathology. J Neurosurg.
79:859–866. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mpairamidis E, Alexiou GA, Stefanaki K,
Sfakianos G and Prodromou N: Brainstem ganglioglioma. J Child
Neurol. 23:1481–1483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yue WY and Chen ZP: Does vasculogenic
mimicry exist in astrocytoma? J Histochem Cytochem. 53:997–1002.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jandial R, Singec I, Ames CP and Snyder
EY: Genetic modification of neural stem cells. Mol Ther.
16:450–457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ahmad F, Pacholska A, Tuppurainen V,
Ylä-Herttuala S and Hyvärinen A: Resectable VX-2 rabbit brain tumor
model for development of intraoperative local administration of
drugs. Acta Neurochir (Wien). 153:1979–1981. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Blümcke I and Wiestler OD: Gangliogliomas:
An intriguing tumor entity associated with focal epilepsies. J
Neuropathol Exp Neurol. 61:575–584. 2002. View Article : Google Scholar
|
|
36
|
Zhu JJ, Leon SP, Folkerth RD, Guo SZ, Wu
JK and Black PM: Evidence for clonal origin of neoplastic neuronal
and glial cells in gangliogliomas. Am J Pathol. 151:565–571.
1997.PubMed/NCBI
|
|
37
|
Im SH, Chung CK, Cho BK, Wang KC, Yu IK,
Song IC, Cheon GJ, Lee DS, Kim NR and Chi JG: Intracranial
ganglioglioma: Preoperative characteristics and oncologic outcome
after surgery. J Neurooncol. 59:173–183. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luyken C, Blümcke I, Fimmers R, Urbach H,
Wiestler OD and Schramm J: Supratentorial gangliogliomas:
Histopathologic grading and tumor recurrence in 184 patients with a
median follow-up of 8 years. Cancer. 101:146–155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pandita A, Balasubramaniam A, Perrin R,
Shannon P and Guha A: Malignant and benign ganglioglioma: A
pathological and molecular study1. Neuro Oncol. 9:124–134. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zentner J, Wolf HK, Ostertun B, Hufnagel
A, Campos MG, Solymosi L and Schramm J: Gangliogliomas: Clinical,
radiological, and histopathological findings in 51 patients. J
Neurol Neurosurg Psychiatry. 57:1497–1502. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Boer K, Troost D, Timmermans W, van Rijen
PC, Spliet WG and Aronica E: Pi3K-mTOR signaling and AMOG
expression in epilepsy-associated glioneuronal tumors. Brain
Pathol. 20:234–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pekmezci M, Villanueva-Meyer JE, Goode B,
Van Ziffle J, Onodera C, Grenert JP, Bastian BC, Chamyan G, Maher
OM, Khatib Z, et al: The genetic landscape of ganglioglioma. Acta
Neuropathol Commun. 6:472018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim NR, Wang KC, Bang JS, Choe G, Park Y,
Kim SK, Cho BK and Chi JG: Glioblastomatous transformation of
ganglioglioma: Case report with reference to molecular genetic and
flow cytometric analysis. Pathol Int. 53:874–882. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Penisson M, Ladewig J, Belvindrah R and
Francis F: Genes and mechanisms involved in the generation and
amplification of basal radial glial cells. Front Cell Neurosci.
13:3812019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang H, Lafdil F, Wang L, Park O, Yin S,
Niu J, Miller AM, Sun Z and Gao B: Hepatoprotective versus
oncogenic functions of STAT3 in liver tumorigenesis. Am J Pathol.
179:714–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Guadagno E, Vitiello M, Francesca P, Calì
G, Caponnetto F, Cesselli D, Camorani S, Borrelli G, Califano M,
Cappabianca P, et al: PATZ1 is a new prognostic marker of
glioblastoma associated with the stem-like phenotype and enriched
in the proneural subtype. Oncotarget. 8:59282–59300. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vitiello M, Palma G, Monaco M, Bello AM,
Camorani S, Francesca P, Rea D, Barbieri A, Chiappetta G, Vita G,
et al: Dual oncogenic/anti-oncogenic role of PATZ1 in FRTL5 rat
thyroid cells transformed by the Ha-Rasv12 oncogene.
Genes (Basel). 10:1272019. View Article : Google Scholar : PubMed/NCBI
|
